General description
Zoledronic acid is a bisphosphonate which reduces bone resorption through inhibition of osteoclast activity.
INN
Zoledronic acid
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2017
(TRS
1006)
for
Malignant neoplasm metastasis in bone or bone marrow
Application rejected in 2023
(TRS
1049)
for
Osteogenesis imperfecta
Wikipedia
DrugBank
Recommendations
Section
Supportive medicines
- Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle
Section
Medicines for endocrine disorders
- Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle
Indications